Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

REQUIREMENT OF TNFR P75 IN ISCHEMIA-INDUCED ANGIOGENESIS

Award Number: R21AG026777
ORGANIZATION: NATIONAL INSTITUTE ON AGING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 02/15/2007
PERIOD OF PERFORMANCE END DATE: 01/31/2009

Group Awards By:

View Award Description

REQUIREMENT OF TNFR P75 IN ISCHEMIA-INDUCED ANGIOGENESIS - DESCRIPTION (provided by applicant): Background: Aging is a risk factor for development of coronary and peripheral artery diseases. The extent of ischemic damage and functional recovery in case of extensive impairment of vascularization is largely depending on the development of new collateral vessels. Tumor necrosis factor alpha (TNF-a), a macrophage/monocyte-derived pluripotent mediator and pro-inflammatory cytokine is expressed in ischemic areas and reported to induce angiogenesis. TNF has been reported to induce the expression of many angiogenesis related genes, through two different TNF receptors, TNFR1 (p55) and TNFR2 (p75). In various vascular ECs, TNF increased the expression of angiogenic factors VEGF, bFGF, IL-8, however, the role of two distinct TNF receptors in mediating these responses are still unclear. Hypothesis: p55 is largely known to mediate cytotoxic effects of TNF, whereas signaling through p75 is mostly implied in protective effects of TNF-alpha and because aging is associated with increased expression of p55 and decreased expression of p75 in cells from aged humans we hypothesized that the p75 may be essential in angiogenic signaling in adults. Purpose: 1) Determine the contribution of TNFR2 p75 on VEGF and bFGF gene expression on EC function in vitro and on angiogenesis in vivo; TNF-induced pro-angiogenic signaling and EC function is mediated, in large part, through p75 TNFR2. 2) Determine molecular mechanisms underlying TNF-mediated ischemia-induced survival and apoptosis signaling in ECs; In the absence of TNFR2 p75 post-ischemic apoptotic signaling is exaggerated. 3) Determine to what extent ischemia-induced mobilization, migration and recruitment of EPCs from bone marrow depends on signaling through p75 TNFR2; a) Ischemia-induced mobilization of EPCs from bone marrow is mediated, at least in part, via TNFR2 p75; b) Functional TNFR2 p75 is necessary for proper contribution of bone marrow-derived EPCs to post-ischemic recovery. Significance: the goal of this proposal is to define certain molecular mechanisms of iscmemia-induced TNF- mediated angiogenic signaling that may be impaired in adult tissue, in part, due to age-associated decrease in TNFR2 p75 expression. In addition, this proposal may lead to an identification of a gene target, which can be used to improve the poor recovery and prevent the development of severe ischemia-induced damage in adult coronary and peripheral vascular diseases.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2008 ( Subtotal = $170,765 )
2008	2008	CARITAS ST ELIZABETH`S MEDICAL CENTER OF BOSTON	736 CAMBRIDGE ST, BOX OLH-6BD	BOSTON	MA	02135	SUFFOLK	USA	Aging Research	000	2	2/20/2008	NON-COMPETING CONTINUATION	$170,765
														Subtotal = $170,765

Issue Date FY: 2007 ( Subtotal = $209,100 )
2007	2007	CARITAS ST ELIZABETH`S MEDICAL CENTER OF BOSTON	736 CAMBRIDGE ST, BOX OLH-6BD	BOSTON	MA	02135	SUFFOLK	USA	Aging Research	000	1	2/6/2007	NEW	$209,100
														Subtotal = $209,100

Grand Total All Awards = $379,865

Top

All Categories

About

Search

Reports

Data Submission

Award Information

REQUIREMENT OF TNFR P75 IN ISCHEMIA-INDUCED ANGIOGENESIS

Award Number: R21AG026777

ORGANIZATION: NATIONAL INSTITUTE ON AGING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 02/15/2007

PERIOD OF PERFORMANCE END DATE: 01/31/2009

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer